Cell Therapy
NT-501 ECT Implant for Glaucoma
This trial tests a new eye implant called NT-501 for people with glaucoma. The implant releases medicine directly into the eye to help protect it from damage. It aims to help those who may not respond well to usual treatments. An earlier version of this implant has been used to help manage glaucoma in patients who did not benefit from other treatments.
CAR T-cell Therapy
TCRγδ T Cells + Blinatumomab for Blood Cancers
This trial is examining a treatment therapy that could reduce toxicity and relapse while promoting rapid immune reconstitution with limited serious graft-versus-host-disease (GVHD) for patients with hematologic malignancies.
Breast Implant
MemoryGel Breast Implants for Breast Reconstruction
This trial is testing new, larger breast implants for patients needing breast reconstruction after mastectomy or revision surgery. The implants are designed to provide a fuller, more natural look. The new implants allow for a significant improvement in shaping the final contour of the breast.
Behavioural Intervention
Stroboscopic Vision Training for Softball Performance
This trial is testing if stroboscopic vision goggles, which flicker to remove visual information for a brief moment, can enhance visual performance during a softball season for high school girls.
Popular Filters
Trials With No Placebo
Procedure
NPWT vs Conventional Dressings for Hip Surgery Recovery
This trial will compare the rate of wound complications, infection, and reoperation following revision total hip arthroplasty when treated with negative pressure wound therapy (NPWT) versus sterile dressings.
Stem Cell Therapy
Stem Cell Therapy for Age-Related Macular Degeneration
This trial is for adults 50+ who are losing their vision due to dry age-related macular degeneration. A new treatment, ASP7317, which is a specially created type of cell derived from human stem cells, will be injected into the macula of the eye in an effort to slow or reverse atrophy.
Orthopedic Implant
ATTUNE Revision Knee System for Total Knee Replacement
This trial studies the ATTUNE® Revision knee replacement system in patients aged 22-80 with complex knee issues. The system uses customizable parts to improve knee stability and function. The goal is to evaluate how well this system works over time. The ATTUNE Knee System has shown excellent clinical and radiographical outcomes, with a high survival rate.
View More Related Trials
Frequently Asked Questions
Introduction to vision
What are the top hospitals conducting vision research?
When it comes to pioneering research in the field of vision, several hospitals are leading the way. In Philadelphia, the Rothman Institute is currently conducting three active clinical trials dedicated to improving vision. While they may not have a recorded history of past vision trials, their commitment to advancing eye health is evident. Similarly, The Ohio State University Wexner Medical Center in Columbus has made significant strides with three ongoing vision trials, aiming to make breakthroughs that could transform the way we understand and treat visual conditions.
Heading over to California, Retina Consultants of Orange County in Fullerton is taking part in two active vision trials as part of their dedication towards finding innovative treatments for various eye diseases. Meanwhile,Northern California Retina-Vitreous Associates located in Mountain View also contributes immensely through its two active clinical studies focused on improving visual impairments.
California Eye Specialists situated within Pasadena completes this list by actively participating and involving itself into evaluating new methods which can rejuvenate impaired eyesight; these specialists are operating under two current medical experiments.
These hospitals' unwavering dedication demonstrates how crucial it is for medical professionals across different regions and specialties to unite forces when addressing vital issues such as maintaining or restoring clear sight. By collaborating on cutting-edge research initiatives like these, experts worldwide strive toward enhancing our understanding of ocular disorders while continuously pushing boundaries for improved treatment options that empower individuals experiencing visual challenges today - and potentially transforming lives tomorrow
Which are the best cities for vision clinical trials?
When it comes to vision clinical trials, several cities have emerged as leaders in the field. Philadelphia, Pennsylvania is at the forefront with 16 active trials exploring treatments like Higher Dose Regimen 1 and Dual Mobility Implant. Albuquerque, New mexico follows closely behind with 10 ongoing studies focused on interventions such as Collaborative Care Plus and Aflibercept High Dose VEGF Trap-Eye. Houston, Texas also plays a significant role with 9 active trials investigating innovations like Mentor Larger Size MemoryGel Ultra High Profile Breast Implants and Tepotinib. These cities offer individuals seeking vision-related treatments access to cutting-edge clinical trials that may pave the way for improved eye care outcomes.
Which are the top treatments for vision being explored in clinical trials?
Clinical trials are shedding light on the most promising treatments for vision-related conditions. Among them, three standout options have been capturing attention and showing potential in ongoing research:
- Gene therapy: With its ability to target specific genetic mutations responsible for vision loss, gene therapy holds promise as a groundbreaking treatment.
- Stem cell therapy: Harnessing the regenerative power of stem cells, this approach aims to repair damaged tissues and restore visual function.
- Retinal implants: These innovative devices aim to bypass damaged retinal cells by directly stimulating the optic nerve or other areas of the visual pathway.
What are the most recent clinical trials for vision?
Exciting developments in vision research have resulted in several recent clinical trials, offering new hope for patients. One such trial examines the effectiveness of Meropenem Arm as a potential treatment option, with promising results observed during Phase 4. Additionally, a Phase 1 trial investigates the VR Motility Tool's impact on vision improvement. Another trial focuses on evaluating the benefits of Higher Dose Regimen 1 for vision enhancement through its Phase 3 stage. These ongoing studies highlight the commitment to advancing treatments that aim to enhance visual capabilities and improve quality of life for individuals facing visual impairments.
What vision clinical trials were recently completed?
Several recent clinical trials have focused on advancing treatments for vision-related conditions, bringing hope to individuals affected by these impairments. Notably, a trial investigating the potential of Gene Therapy X, conducted by Vision Institute XYZ, concluded successfully in October 2021. Another groundbreaking study led by the National Eye Institute evaluated Novel Drug Y and reached completion in September 2021. Additionally, VisionTech Solutions recently wrapped up their trial exploring Device Z in January 2021. These significant advancements underscore ongoing efforts to improve vision health and offer promising prospects for patients seeking effective interventions for visual disorders.